Article: CHIRON SPINS POWDER INJECTION TECHNOLOGY INTO POWDERMED LTD.

Article from:
BIOWORLD Today
Article date:
May 18, 2004
Author:
Copyright

Byline: Nuala Moran, BioWorld International Correspondent

LONDON - Chiron Corp. is spinning out the DNA vaccines technology it acquired when it took over PowderJect Pharmaceuticals plc to a team of former PowderJect managers.

The new company, PowderMed Ltd., raised [pounds sterling]20 million (US$34.5 million) in a private financing and will inherit a long-standing collaboration with GlaxoSmithKline plc, of London. PowderMed has rights to develop vaccines delivered by the needle-free powder injection technology around which PowderJect was formed, and the company starts its independent life with a portfolio of five preclinical

DNA vaccines. The ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Chiron Vaccines Spins Out Powder Injection ...
PR Newswire;  May 17, 2004 ;     700+ words ... ... injection technology. Chiron Vaccines will retain a ... equity stake in PowderMed as consideration ... lung cancer. PowderMed will also progress ... herpes, for which Chiron Vaccines will retain an ... agreement with Chiron Vaccines, Dr. Clive Dix ... Chief Executive of ...

Article: PowderMed Launched in Spin Out of Powder Injection DNA ...
PR Newswire;  May 17, 2004 ;     700+ words ... ... Partners, with Chiron Vaccines retaining ... spin out, PowderMed has acquired ... over from Chiron Vaccines. Initially, PowderMed will focus ... transaction Chiron Vaccines will transfer ... facilities to PowderMed as well as ...

Article: Chiron Spins Powder Injection Technology Into PowderMed ...
BIOWORLD Today;  November 3, 2009 ;     700+ words ... ... staff members from Chiron Vaccines will join PowderMed, which will be ... president of Chiron Vaccines, said powder injection ... did not fit with Chiron Vaccines' research and ... stewardship of PowderMed, with its experienced ...

Article: PowderMed Initiates a Phase I Clinical Trial for a Novel ...
PR Newswire;  October 12, 2004 ;     700+ words ... ... immunity. Notes for Editors 1. About PowderMed Ltd - http://www.powdermed.com/ PowderMed Ltd, a leader in the development of ... vaccine programmes, previously owned by Chiron Vaccines. The Company has the rights to the PowderJect ...

Article: Ludwig Institute for Cancer Research and PowderMed ...
PR Newswire;  September 17, 2004 ;     700+ words ... ... antigens". Notes for Editors 1. About PowderMed Ltd - http://www.powdermed.com/ PowderMed Ltd, a leader in the development of ... vaccine programmes, previously owned by Chiron Vaccines. The Company has the rights to the PowderJect ...

Article: Positive Outcome of Phase I DNA Influenza Study; PowderMed ...
PR Newswire;  November 18, 2004 ;     700+ words ... ... PowderMed Ltd - http://www.powdermed.com/ PowderMed Ltd, based in Oxford, United Kingdom ... injection DNA Vaccines technology from Chiron Vaccines, a business unit of Chiron Corporation . PowderMed has acquired the rights to the PowderJect ...

Article: New UK-based vaccines firm, PowderMed, spins out from ...
Pharma Marketletter;  May 24, 2004 ;     700+ words ... ... its former R&D staff. PowderMed's new shareholders include Schroder ... Oxford Bioscience Partners, with Chiron Vaccines retaining a minority equity stake ... produce a therapeutic effect. PowderMed's lead preclinical programs ...

Article: PowderMed to trial three vaccines.(Vaccines)(Brief ...
Chemistry and Industry;  November 1, 2004 ;     700+ words ... ... system to treat disease. PowderMed's technology involves depositing ... antigen on their surface. PowderMed's cancer vaccine uses a ... virus replicating itself. PowderMed was launched in May 2004 ... programs previously owned by Chiron Vaccines. The company hopes to bring ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives